banbao(603398)

Search documents
沐邦高科:江西沐邦高科股份有限公司关于召开2024年半年度业绩说明会的公告
2024-09-27 10:17
证券代码:603398 证券简称:沐邦高科 公告编号:2024-082 江西沐邦高科股份有限公司 关于召开 2024 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 投资者可于 2024 年 10 月 8 日(星期二)至 10 月 14 日(星期一)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 (zqb@mubon.com.cn)进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 重要内容提示: 会议召开时间:2024 年 10 月 15 日(星期二)15:00-16:00 会 议 召 开 地 点 : 上海证券 交 易 所 上 证 路 演 中 心 ( 网 址 : https://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 江西沐邦高科股份有限公司(以下简称"公司")已于 2024 年 8 月 30 日发 布了公司 2024 年半年度报告,为便于广大投资者更全面深入地了解公司 2024 年 半年度的经营成果、财务状况,公司计 ...
沐邦高科:江西沐邦高科股份有限公司关于控股股东股份质押的公告
2024-09-24 09:12
| 股东 | 是否为 | 本次质押 | 是否 | 是否补 | 质押起 | 质押到 | | 占其所 | 占公司 | 质押融 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 控股股 | 股数 | 为限 | 充质押 | 始日 | 期日 | 质权人 | 持股份 | 总股本 | 资资金 | | | 东 | | 售股 | | | | | 比例 | 比例 | 用途 | | 汕头市邦 领贸易有 | 是 | 10,000,00 0 股 | 否 | 否 | 年 2024 9 月 23 | 至解除 质押登 | 深圳智卓投 资咨询合伙 企业(有限 | 11.42% | 2.31% | 生产经 营 | | 限公司 | | | | | 日 | 记日止 | 合伙) | | | | | 合计 | / | 10,000,00 0 股 | / | / | / | / | / | 11.42% | 2.31% | / | 证券代码:603398 证券简称:沐邦高科 公告编号:2024-080 江西沐邦高科股份有限公司 关于控股股东股份质押的公 ...
沐邦高科:江西沐邦高科股份有限公司关于下属公司涉及诉讼及为其提供担保的公告
2024-09-24 09:12
关于下属公司涉及诉讼及为其提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 案件所处的诉讼阶段:双方已达成调解协议 上市公司及子公司所处的当事人地位:被告及第三人 证券代码:603398 证券简称:沐邦高科 公告编号:2024-081 江西沐邦高科股份有限公司 截至本公告披露日,公司及控股子公司对外担保总额为 10.07 亿元,占 公司最近一期经审计净资产的比例为 135.31%,请投资者充分关注担保风险。 一、本次诉讼的基本情况 江西沐邦高科股份有限公司(以下简称"公司")下属公司内蒙古沐邦兴材 新材料有限公司(以下简称"沐邦兴材")与镇江西门子母线有限公司产生买卖 合同纠纷,原告镇江西门子母线有限公司要求被告沐邦兴材支付货款 3,531,535.63 元,并承担逾期付款违约金暂计 20 万元,被告沐邦兴材的控股股东 内蒙古沐邦新材料有限公司自愿作为第三人参加本案诉讼,为债务承担连带清偿 责任。上述案件详见公司在上海证券交易所网站及指定信息披露媒体上披露的公 司《2024 年半年度报告》。 ...
沐邦高科:江西沐邦高科股份有限公司关于控股股东部分股份解除质押的公告
2024-09-23 08:58
证券代码:603398 证券简称:沐邦高科 公告编号:2024-079 江西沐邦高科股份有限公司 关于控股股东部分股份解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 截至本公告披露日,江西沐邦高科股份有限公司(以下简称"公司")控 股股东汕头市邦领贸易有限公司(以下简称"邦领贸易")持有公司股份87,540,610 股,占本公司股份总数的 20.19%。本次解除质押 10,000,000 股,解除质押后, 邦领贸易累计质押本公司股份数量为 58,300,000 股,占其所持有公司股份总数的 66.60%,占公司总股本的 13.44%。 公司控股股东邦领贸易于 2024 年 9 月 20 日将其质押的 10,000,000 股无限售 流通股办理了解除质押,具体情况如下: | 股东名称 | 汕头市邦领贸易有限公司 | | --- | --- | | 本次解质股份 | 10,000,000 股 | | 占其所持股份比例 | 11.42% | | 占公司总股本比例 | 2.31% | | 解质时间 ...
沐邦高科:江西沐邦高科股份有限公司关于高级管理人员离职的公告
2024-08-30 09:03
特此公告。 江西沐邦高科股份有限公司董事会 二〇二四年八月三十一日 江西沐邦高科股份有限公司(以下简称"公司")董事会于近日收到公司董 事会秘书兼副总经理刘韬先生提交的书面辞职报告。因个人原因,刘韬先生申请 辞去公司董事会秘书、副总经理的职务,辞职后将不再担任公司的其他任何职务, 该辞职报告自送达董事会之日起生效。 刘韬先生在担任公司董事会秘书期间恪尽职守、勤勉尽责,在公司信息披露、 规范运作、资本运作、投资者关系管理等方面发挥了重要作用。公司董事会对刘 韬先生在其任职期间为公司发展所做出的贡献表示衷心的感谢。 后续公司董事会将根据相关规定,尽快聘任新的董事会秘书并及时履行信息 披露义务。 证券代码:603398 证券简称:沐邦高科 公告编号:2024-077 江西沐邦高科股份有限公司 关于高级管理人员离职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 ...
沐邦高科:江西沐邦高科股份有限公司关于计提信用减值损失和资产减值损失的公告
2024-08-29 09:43
证券代码:603398 证券简称:沐邦高科 公告编号:2024-073 江西沐邦高科股份有限公司 关于计提信用减值损失和资产减值损失的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 江西沐邦高科股份有限公司(以下简称"公司")于 2024 年 8 月 28 日召开了 第四届董事会第四十五次会议和第四届监事会第二十三次会议,审议通过了《关 于计提信用减值损失和资产减值损失的议案》。 根据《企业会计准则》的相关规定,公司对应收款项按照整个存续期的预期 信用损失计量坏账准备,并对相关资产可能存在的减值风险进行预计。本着谨慎 性原则,公司及子公司 2024 年上半年共计提信用减值损失-6,916,120.64 元,计 提资产减值损失 45,499,579.30 元,合计 38,583,458.66 元。现就相关情况公告如 下: 一、本次计提信用减值损失和资产减值损失情况 (一)信用减值损失 (1)应收票据坏账损失 公司按照账龄组合对其他的应收账款计提坏账准备-1,408,902.45 元。 (3)其他应收款坏账损失 202 ...
沐邦高科:江西沐邦高科股份有限公司关于与控股股东续签借款合同暨关联交易的公告
2024-08-29 09:43
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 江西沐邦高科股份有限公司 证券代码:603398 证券简称:沐邦高科 公告编号:2024-072 重要内容提示: 1、江西沐邦高科股份有限公司(以下简称"公司")拟与关联方汕头市邦领 贸易有限公司(以下简称"邦领贸易")续签借款合同,向控股股东获取借款,借 款额度不超过人民币 4.5 亿元,借款期限共计 12 个月。在此额度和期限内,公 司可以滚动使用。借款利率 3.35%/年且不高于一年期商业银行公告的同期贷款 利率。 2、本次借款构成关联交易,不构成《上市公司重大资产重组管理办法》规 定的重大资产重组。 3、本次借款事项已经公司第四届董事会第四十五次会议及第四届监事会第 二十三次会议审议通过。根据《上海证券交易所股票上市规则》等相关规定,无 需提交公司股东大会审议。 关于与控股股东续签借款合同暨关联交易的公告 4、截至本公告日借款余额为人民币 4,334.80 万元。 一、关联交易概述 (一)2023 年 9 月 5 日,公司第四届董事会第三十一次会议审议通过了《关 于 ...
沐邦高科:江西沐邦高科股份有限公司第四届监事会第二十三次会议决议公告
2024-08-29 09:43
证券代码:603398 证券简称:沐邦高科 公告编号:2024-071 江西沐邦高科股份有限公司 二、监事会会议审议情况 本次会议由监事会主席田原女士主持,经与会监事审议,以记名投票表决方 式通过如下议案: (一)审议通过《关于<江西沐邦高科股份有限公司 2024 年半年度报告>及 其摘要的议案》 表决情况:3 票同意,0 票反对,0 票弃权;获全体监事一致通过。 (二)审议通过《关于公司与控股股东续签借款合同暨关联交易的议案》 表决情况:3 票同意,0 票反对,0 票弃权;获全体监事一致通过。 第四届监事会第二十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 江西沐邦高科股份有限公司(以下简称"公司")第四届监事会第二十三次会 议于 2024 年 8 月 28 日在公司 6 楼会议室以现场结合通讯的表决方式召开。本 次会议应出席监事 3 人,实际出席监事 3 人。本次会议的召开符合《公司法》、 《上海证券交易所股票上市规则》等相关法律法规、规范性文件以及《江西沐邦 高科股份有限 ...
沐邦高科(603398) - 2024 Q2 - 季度财报
2024-08-29 09:41
Financial Performance - The company's operating revenue for the first half of 2024 was approximately ¥435.77 million, a decrease of 31.95% compared to ¥640.41 million in the same period last year[14]. - The net profit attributable to shareholders for the first half of 2024 was approximately -¥154.37 million, a decline of 1,444.40% compared to a profit of ¥11.48 million in the same period last year[15]. - The net cash flow from operating activities was approximately -¥92.11 million, a decrease of 140.65% compared to ¥226.58 million in the same period last year[15]. - The company's operating revenue for the reporting period was ¥435,774,272.85, a decrease of 31.95% year-on-year[16]. - The net profit attributable to shareholders was -¥154,368,971.29, a year-on-year decrease of 1,444.40%[16]. - The net cash flow from operating activities was -¥92,105,079.74, a decrease of 140.65% year-on-year, primarily due to government subsidies received in the same period last year amounting to ¥248 million[16]. - The weighted average return on equity was -9.64%, a decrease of 11.23 percentage points compared to the same period last year[16]. - The company reported a basic earnings per share of -¥0.36, a decline of 1,300.00% year-on-year[16]. - The company reported a significant increase in cash and cash equivalents, rising by 284.02% to RMB 422.24 million[47]. - The company reported a significant decrease in long-term payables, down 34.26% to 14,199,559.41 RMB from 21,599,064.01 RMB[48]. - The company reported a net loss of CNY 208,368,837.68, compared to a loss of CNY 53,999,866.39 in the previous period[104]. - The net loss for the first half of 2024 was CNY 155,234,922.48, compared to a net profit of CNY 11,223,395.23 in the first half of 2023, indicating a significant decline in profitability[109]. - The company reported a comprehensive income total of -62,986,234.26 RMB for the current period, indicating a loss in this category[126]. Assets and Liabilities - The total assets at the end of the reporting period were approximately ¥5.30 billion, an increase of 15.95% compared to ¥4.58 billion at the end of the previous year[15]. - The total assets of the company increased to ¥5,304,930,807.04, reflecting a year-on-year growth of 15.95% due to the increase in raised funds during the reporting period[16]. - The company's equity attributable to shareholders increased to CNY 1,991,944,136.12 from CNY 744,562,158.50, marking a substantial rise of approximately 167.5%[104]. - The total liabilities decreased to CNY 3,315,979,781.14 from CNY 3,832,853,645.79, showing a reduction of about 13.5%[104]. - The company's total liabilities decreased to CNY 1,206,158,855.60 from CNY 1,702,405,858.86, indicating improved financial health[107]. - The company's total capital contributions from owners increased by 1,401,750,948.91 RMB during the first half of 2024[124]. Shareholder Information - The company held three shareholder meetings in 2024, with all resolutions passed successfully[57]. - The first extraordinary shareholder meeting on February 23, 2024, approved the investment in a high-efficiency battery project[58]. - The second extraordinary shareholder meeting on April 8, 2024, approved the investment in a 16GW N-type high-efficiency monocrystalline silicon rod project[58]. - The annual shareholder meeting on May 20, 2024, included a proposal for a three-year shareholder dividend return plan from 2024 to 2026[58]. - The total number of common shareholders as of the end of the reporting period is 14,323[94]. - The largest shareholder, Shantou Bangling Trading Co., holds 87,540,610 shares, accounting for 20.19% of total shares[94]. - The second largest shareholder, Bangling International Ltd., holds 55,881,348 shares, representing 12.89% of total shares[94]. - The top ten shareholders collectively hold a significant portion of the company's shares, with the top three alone accounting for over 38%[94]. Business Operations - The company operates a direct sales model for its silicon products, signing annual framework contracts with downstream solar cell or module manufacturers[29]. - The company has established stable partnerships with numerous well-known photovoltaic cell or module companies, enhancing its customer resource advantage[38]. - The company’s main products in the silicon business include solar single crystal wafers with specifications of 182mm and 210mm, aligning with market demand for larger wafers[35]. - The company’s toy business includes various series such as educational toys and programming robots, with a focus on enhancing product entertainment and educational value through continuous R&D investment[32]. - The company is focusing on market expansion and new product development as part of its strategic initiatives for future growth[110]. Legal and Compliance Issues - The company is involved in a significant lawsuit regarding a sales contract dispute, with a claim amount of 2,737,400 RMB, and the court has ordered the defendant to return 2.3 million RMB to the plaintiff[71]. - The company has received only 1 million RMB back from the total claim, leaving 2.43 million RMB unresolved[72]. - The company is pursuing compensation of 10,510,418.22 RMB due to issues with customs clearance for Ultraman series products, which were unable to be exported[73]. - The ongoing litigation regarding the Ultraman licensing agreement is set to be heard in court on August 16, 2024[72]. - The company has a pending lawsuit against Guangxi Mubang High-tech New Energy, with a claim amount of CNY 10,808,539.60, and a court ruling for payment in four installments by the end of 2024[74]. - The company has faced a total of CNY 34,021.97 and CNY 3,107.31 frozen in its bank accounts due to a dispute with Shanghai Xiewei Environmental Technology Co., Ltd.[77]. Investment and Capital Expenditure - The company completed a private placement of 91,007,017 shares, raising a net amount of approximately RMB 1.40 billion[43]. - The company signed an investment agreement to build a production base for 10GW-N high-efficiency battery cells and 10GW slicing, with 50% of the main plant's steel structure and 60% of civil works completed[43]. - The company plans to invest in a 16GW N-type high-efficiency monocrystalline silicon rod project in Shanxi Province, with construction ongoing[43]. - The company has allocated RMB 572,889,324.86 for the construction of a 10,000 tons/year intelligent silicon purification and recycling project, with 25.69% of the funds utilized to date[84]. Risk Management - The company has outlined potential risks and corresponding measures in the report, urging investors to be cautious[4]. - The company faces risks from industry cyclicality and intensified competition in the silicon wafer and rod business, which may weaken profitability if price recovery is slower than expected[54]. - The company is implementing strategies to enhance production efficiency and control costs in response to rising raw material prices and external economic pressures[55]. Research and Development - The company submitted over 30 patent applications in the first half of 2024, with 5 patents granted, focusing on improving the efficiency of single crystal rod production and single crystal furnace development[41]. - Research and development expenses increased to CNY 26,056,562.57 in the first half of 2024, up from CNY 20,830,618.70 in the same period of 2023, highlighting a focus on innovation[109]. - Research and development expenditures during the research phase are recognized as expenses in the current period, while expenditures during the development phase can be capitalized if specific criteria are met[186][187]. Compliance and Governance - The company has fulfilled its commitments related to major asset restructuring and initial public offerings[63]. - The company guarantees that during its shareholding period, it will avoid engaging in any business activities that may compete with its subsidiary, ensuring priority for the subsidiary in any competitive investment opportunities[68]. - The company has committed to maintaining its independence and not interfering in the management activities of the listed company, ensuring no infringement on the company's interests[67]. - The company will publicly disclose any stock sales in advance and ensure compliance with regulatory requirements[66].
沐邦高科:国金证券股份有限公司关于江西沐邦高科股份有限公司使用部分闲置募集资金临时补充流动资金的核查意见
2024-08-29 09:41
国金证券股份有限公司 关于江西沐邦高科股份有限公司 使用部分闲置募集资金临时补充流动资金的核查意见 国金证券股份有限公司(以下简称"国金证券"或"保荐人")作为江西沐 邦高科股份有限公司(以下简称"沐邦高科"或"公司")向特定对象发行股票 的保荐人,根据《证券发行上市保荐业务管理办法》《上海证券交易所股票上市 规则》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》 《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关法律、法 规和规范性文件的规定,对沐邦高科使用部分闲置募集资金临时补充流动资金的 事项进行了核查,具体情况如下: 一、募集资金基本情况 根据中国证监会出具的《关于同意江西沐邦高科股份有限公司向特定对象发 行股票注册的批复》(证监许可〔2023〕2928 号),公司向特定对象发行人民币 普通股 91,007,017 股,每股发行价 15.58 元,募集资金总额为人民币 1,417,889,324.86 元,扣除不含增值税发行费用人民币 16,138,375.95 元后,实际 募集资金净额为人民币 1,401,750,948.91 元。 2024 年 2 月 6 日 ...